Kyle P. Hammond

Most-cited papers

1. Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.

   C. Aquilante, Lisa A. Kosmiski, D. Bourne, L. Bushman +10 more

   2013British Journal of Clinical Pharmacology61 citations Open access

   Semantic Scholar

   Save

2. Pharmacokinetic Interaction Between Boceprevir and Etravirine in HIV/HCV Seronegative Volunteers

   Kyle P. Hammond, P. Wolfe, J. Burton, Julie A. Predhomme +4 more

   2013Journal of Acquired Immune Deficiency Syndromes30 citations Open access

   Semantic Scholar

   Save

3. Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection

   Liviawati S. Wu, J. Rower, J. Burton, P. Anderson +6 more

   2015Antimicrobial Agents and Chemotherapy29 citations Open access

   Semantic Scholar

   Save

4. Validation of a LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study

   J. Rower, L. Bushman, Kyle P. Hammond, R. Kadam +1 more

   2010Biomedical chromotography16 citations Open access

   Semantic Scholar

   Save

5. Priapism induced by boceprevir-CYP3A4 inhibition and α-adrenergic blockade: case report.

   Kyle P. Hammond, C. Nielsen, S. Linnebur, Jacob A. Langness +3 more

   2014Clinical Infectious Diseases8 citations Open access

   Semantic Scholar

   Save

6. Su1590 PHARMACIST DRIVEN MODELS OF CARE FOR HEPATITIS C VIRUS ELIMINATION: REAL WORLD COHORTS

   Michelle T. Martin, Macy Ho, D. Koren, S. Mehta +5 more

   20200 citations

   Semantic Scholar

   Save

7. Virologic Response Rates to Fixed-Dose Combination Ledipasvir/Sofosbuvir for 8 or 12 Weeks With Baseline Viral Load: 2061

   T. Hawkins, S. Arora, G. Everson, B. Freilich +7 more

   20150 citations

   Semantic Scholar

   Save